Two sizable companies and a handful of small Asian issuers were listed in the US this past week. Read more here.
The biotech is evaluating several cystic fibrosis medicines that could either work alongside Vertex’s top-selling Trikafta or ...
Cystic fibrosis-focused Sionna Therapeutics is joining the Nasdaq this morning with an upsized public offering, while obesity ...
The Massachusetts-based biotech plans to use the funds to push its candidates into mid-stage clinical trials in a space ...
Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers ...
Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers from the Technical University of Munich (TUM) have discovered that the ...
A study led by TUM researchers finds that cystic fibrosis alters immune cells early in life, likely before birth. These ...
When cystic fibrosis hits your lungs hard, hit back. Everything you need to know about getting your lungs back into shape is ...
The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for ...
Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers from the Technical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback